Gritstone bio, Inc.
GRTS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$138,490 | -$119,687 | -$75,082 | -$105,314 |
| Dep. & Amort. | $7,591 | $6,560 | $6,347 | $6,644 |
| Deferred Tax | $1,968 | $0 | $817 | -$122 |
| Stock-Based Comp. | $11,618 | $12,557 | $10,552 | $7,110 |
| Change in WC | -$17,135 | -$24,527 | -$1,364 | -$4,931 |
| Other Non-Cash | $12,800 | $9,151 | $8,052 | $7,511 |
| Operating Cash Flow | -$121,648 | -$115,946 | -$50,678 | -$89,102 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,572 | -$5,872 | -$5,463 | -$3,515 |
| Net Acquisitions | -$106,913 | $7,092 | $0 | -$69,464 |
| Inv. Purchases | -$26,295 | -$141,908 | -$199,905 | -$8,809 |
| Inv. Sales/Matur. | $133,208 | $134,816 | $87,053 | $78,273 |
| Other Inv. Act. | $106,913 | -$7,092 | -$238 | $69,464 |
| Investing Cash Flow | $102,341 | -$12,964 | -$118,553 | $65,949 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $19,679 | $18,902 | -$56 | $0 |
| Stock Issued | $8,092 | $64,737 | $112,888 | $134,796 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,654 | -$541 | -$4,072 | $1,005 |
| Financing Cash Flow | $25,117 | $83,098 | $108,760 | $135,801 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,810 | -$45,812 | -$60,471 | $112,648 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59,475 | $110,577 | $171,048 | $58,400 |
| End Cash | $65,285 | $64,765 | $110,577 | $171,048 |
| Free Cash Flow | -$126,220 | -$121,818 | -$56,141 | -$92,617 |